Episode 299: Androgen receptor ligand-directed degrader BMS-986365
Listen now
Description
Dana Rathkopf describes phase 1 data for the androgen receptor ligand-directed degrader in prostate cancer
More Episodes
Silke Gillessen joins Tom and Brian, who give their opinion on the data and new 'Take Home Message' format.
Published 06/10/24
Published 06/10/24
Nobuaki Matsubara, Hiroshi Kitamura and Yuji Miura battle through the sometimes ridiculous questions set by Tom and Brian.
Published 06/07/24